{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:53:09Z","timestamp":1787320389531,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02646","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T01:54:52Z","timestamp":1542246892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice"],"prefix":"10.3389","volume":"9","author":[{"given":"Sladjana","family":"Pavlovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemanja","family":"Jovicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Ljujic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Miletic Kovacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebojsa","family":"Arsenijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miodrag L.","family":"Lukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nm.3042","article-title":"Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes","volume":"19","author":"Diana","year":"2013","journal-title":"Nat Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.immuni","article-title":"Prediction and pathogenesis in type 1 diabetes","volume":"32","author":"Ziegler","year":"2010","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-4939-3139-2_8","article-title":"Autoimmune diabetes: an overview of experimental models and novel therapeutics","volume":"1371","author":"You","year":"2016","journal-title":"Methods Mol Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/eji.200535325","article-title":"IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin","volume":"36","author":"Mensah-Brown","year":"2006","journal-title":"Eur J Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molimm.2008.12.023","article-title":"Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin","volume":"47","author":"Zdravkovic","year":"2009","journal-title":"Mol Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11892-016-0739-1","article-title":"Promoting immune regulation in type 1 diabetes using low-dose interleukin-2","volume":"16","author":"Dwyer","year":"2016","journal-title":"Curr Diab Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-elated protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.4049\/jimmunol.181.11.8170","article-title":"IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4","volume":"181","author":"Kurowska-Stolarska","year":"2008","journal-title":"J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/eji.201041033","article-title":"IL-33-activated dendritic cells are critical for allergic airway inflammation","volume":"41","author":"Besnard","year":"2011","journal-title":"Eur J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1006345","DOI":"10.1371\/journal.ppat.1006345","article-title":"IL-33\/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection","volume":"13","author":"Popovic","year":"2017","journal-title":"PLoS Pathog."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/eji.201141947","article-title":"IL-33 attenuates EAE by suppressing IL-17 and IFN-\u03b3 production and inducing alternatively activated macrophages","volume":"42","author":"Jiang","year":"2012","journal-title":"Eur J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e45225","DOI":"10.1371\/journal.pone.0045225","article-title":"Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB\/C mice by enhancing polarization of APC to inflammatory phenotype","volume":"7","author":"Milovanovic","year":"2012","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.trsl.2012.10.005","article-title":"ST2 Gene-Deletion reveals a role of Foxp3+ regulatory t cells in diabetes modulation in BALB\/c mice","volume":"161","author":"Zdravkovic","year":"2013","journal-title":"Transl Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"96600","DOI":"10.1172\/jci.insight.96600","article-title":"CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms","volume":"3","author":"Yuan","year":"2018","journal-title":"JCI Insight"},{"key":"B17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.diabres.2017.04.011","article-title":"IL-33 improves the suppressive potential of regulatory T cells in patients with type 1 diabetes","volume":"128","author":"Ryba-Stanis\u0142awowska","year":"2017","journal-title":"Diabetes Res Clin Pract."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0161507","DOI":"10.1371\/journal.pone.0161507","article-title":"IL-33 Receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 T cell proliferation through IL-10 and TGF\u03b2 release","volume":"11","author":"Siede","year":"2016","journal-title":"PLoS ONE"},{"key":"B19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.180605","article-title":"Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies","volume":"193","author":"Like","year":"1976","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clim.2010.10.010","article-title":"Intravenous immunoglobulins exposed to heme (heme IVIG) are more efficient than IVIG in attenuating autoimmune diabetes","volume":"138","author":"Pavlovic","year":"2011","journal-title":"Clin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1006\/jaut.1999.0331","article-title":"Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway","volume":"3","author":"Ablamunits","year":"1999","journal-title":"J Autoimmun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1365-2567.2007.02724.x","article-title":"Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies","volume":"123","author":"Hall","year":"2008","journal-title":"Immunology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/nprot.2009.150","article-title":"A protocol for islet isolation from mouse pancreas","volume":"4","author":"Li","year":"2009","journal-title":"Nat Protoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.2337\/db12-0222","article-title":"Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets","volume":"62","author":"Pejnovic","year":"2013","journal-title":"Diabetes"},{"key":"B25","first-page":"311","article-title":"Resistance to the induction of EAE in AO rats: its prevention by the pre-treatment with cyclophosphamide or low dose of irradiation","volume":"50","author":"Mostarica-Stojkovi\u0107","year":"1982","journal-title":"Clin Exp Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"587376","DOI":"10.1155\/2014\/587376","article-title":"Role of IL-33 and its receptor in T cell-mediated autoimmune diseases","volume":"2014","author":"Zhao","year":"2014","journal-title":"Biomed Res Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/CIRCRESAHA.110.218867","article-title":"Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice","volume":"107","author":"Miller","year":"2010","journal-title":"Circ Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"913041","DOI":"10.1155\/2015\/913041","article-title":"IL-33 Aggravates DSS-induced acute colitis in mouse colon lamina propria by enhancing Th2 cell responses","volume":"2015","author":"Zhu","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL 33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander","year":"2013","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/ajt.13542","article-title":"Elevated ST2 distinguishes incidences of pediatric heart and small bowel transplant rejection","volume":"16","author":"Mathews","year":"2016","journal-title":"Am J Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2011.03.022","article-title":"Protective role of IL-33\/ST2 axis in Con A-induced hepatitis","volume":"56","author":"Volarevic","year":"2012","journal-title":"J Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","article-title":"IL-33-activated dendritic cells induce an atypical TH2-type response","volume":"123","author":"Rank","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.4049\/jimmunol.180.4.2443","article-title":"IL-33, a potent inducer of adaptive immunity to intestinal nematodes","volume":"180","author":"Humphreys","year":"2008","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.4049\/jimmunol.170.4.1649","article-title":"Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice","volume":"170","author":"Hill","year":"2003","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2015.05.019","article-title":"Interleukin-33 and interferon-\u03b3 counter-regulate group 2 innate lymphoid cell activation during immune perturbation","volume":"43","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12026-012-8283-9","article-title":"IL-33\/ST2 axis in inflammation and immunopathology","volume":"52","author":"Milovanovic","year":"2012","journal-title":"Immunol Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10875-011-9549-z","article-title":"A distinct role of CD4+Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis","volume":"31","author":"Ankathatti","year":"2011","journal-title":"J Clin Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunit"},{"key":"B41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2119\/molmed.2014.00178","article-title":"Galectin-3 ablation enhances liver steatosis, but attenuates inflammation and IL-33-dependent fibrosis in obesogenic mouse model of nonalcoholic steatohepatitis","volume":"21","author":"Jeftic","year":"2015","journal-title":"Mol Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3389\/fimmu.2018.02004","article-title":"Regulatory mechanisms of IL-33-ST2-mediated allergic inflammation","volume":"9","author":"Takatori","year":"2018","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","article-title":"IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2+ regulatory T cells","volume":"193","author":"Matta","year":"2014","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9429760","DOI":"10.1155\/2016\/9429760","article-title":"IL-33 Effect on quantitative changes of CD4+CD25highFOXP3+ regulatory T cells in children with type 1 diabetes","volume":"2016","author":"Ryba-Stanis\u0142awowska","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.4049\/jimmunol.181.4.2483","article-title":"CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1073\/pnas.1115308109","article-title":"Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+CD11b+ dendritic cells","volume":"109","author":"Kriegel","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3389\/fimmu.2018.01565","article-title":"Type-I Interferons inhibit interleukin-10 signaling and favor type 1 diabetes development in nonobese diabetic mice","volume":"9","author":"Iglesias","year":"2018","journal-title":"Front Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T01:54:55Z","timestamp":1542246895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2018.02646"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02646","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"article-number":"2646"}}